Chardan Healthcare Acquisition 2 Corp (CHAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CHAQ | AMGN | VRTX | BMY | GILD |
| Company | Chardan Healthcare Acquisition 2 Corp | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 9.35 | 325.00 | 505.35 | 56.34 | 91.00 |
| High | 9.35 | 325.39 | 506.65 | 56.80 | 91.98 |
| Low | 8.06 | 318.17 | 485.29 | 55.14 | 90.50 |
| Last | 8.41 | 321.79 | 493.64 | 55.28 | 91.69 |
| Change | -0.95 | +2.50 | -6.24 | -0.67 | +1.47 |
| % Change | -10.15% | +0.78% | -1.25% | -1.20% | +1.63% |
| Volume | 242,600 | 2,208,800 | 1,648,700 | 11,775,900 | 8,819,200 |
| 20-Day Average Volume | 87,520 | 1,763,530 | 1,105,035 | 8,783,160 | 5,289,690 |
| Previous Close | 9.36 | 319.29 | 499.88 | 55.95 | 90.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.87 | 319.69 | 480.19 | 53.36 | 87.80 |
| 20-Day Raw Stochastic | 14.23% | 60.19% | 70.10% | 72.31% | 96.29% |
| 20-Day Relative Strength | 17.92% | 50.66% | 57.61% | 60.94% | 73.09% |
| Weighted Alpha | -24.94 | +18.03 | +30.48 | +16.33 | +30.52 |
| Today's Opinion | 100% Sell | 24% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 40% Sell | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.07% since 08/26/21 | +1.98% since 10/30/24 | +3.91% since 10/30/24 | +4.98% since 10/30/24 | +3.85% since 10/30/24 |
| Low | 8.06 on 09/02/21 | 313.02 on 11/05/24 | 463.14 on 11/01/24 | 53.56 on 10/31/24 | 87.74 on 10/31/24 |
| High | 10.52 on 08/30/21 | 325.39 on 11/06/24 | 506.65 on 11/06/24 | 56.80 on 11/06/24 | 91.98 on 11/06/24 |
| 1-Month | |||||
| %Chg | -16.65% since 08/02/21 | +0.67% since 10/04/24 | +8.42% since 10/04/24 | +2.45% since 10/04/24 | +8.39% since 10/04/24 |
| Low | 8.06 on 09/02/21 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 10.52 on 08/30/21 | 329.17 on 10/11/24 | 506.65 on 11/06/24 | 56.80 on 11/06/24 | 91.98 on 11/06/24 |
| 3-Month | |||||
| %Chg | -16.36% since 06/02/21 | -2.18% since 08/06/24 | +4.08% since 08/06/24 | +16.85% since 08/06/24 | +23.59% since 08/06/24 |
| Low | 8.06 on 09/02/21 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 10.52 on 08/30/21 | 339.17 on 09/23/24 | 506.65 on 11/06/24 | 56.80 on 11/06/24 | 91.98 on 11/06/24 |
| 6-Month | |||||
| %Chg | -17.39% since 03/02/21 | +7.45% since 05/06/24 | +22.64% since 05/06/24 | +25.92% since 05/06/24 | +39.90% since 05/06/24 |
| Low | 8.06 on 09/02/21 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 10.52 on 08/30/21 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.80 on 11/06/24 | 91.98 on 11/06/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 90,643 | 171,628,928 | 129,020,016 | 113,476,496 | 112,323,168 |
| Shares Outstanding, K | 10,778 | 537,533 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -780,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -490,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | 0.05 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/17/21 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | N/A | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.49 | 0.00 | 47.39 | 19.11 |